Comparative analysis of Onyx, squid, and n-BCA in middle meningeal artery embolization for chronic subdural hematoma: a meta-analysis of randomized controlled trials
- PMID: 40392287
- DOI: 10.1007/s00234-025-03651-9
Comparative analysis of Onyx, squid, and n-BCA in middle meningeal artery embolization for chronic subdural hematoma: a meta-analysis of randomized controlled trials
Abstract
Background: Selection of an embolic agent for middle meningeal artery embolization (MMAE) in a chronic subdural hematoma (cSDH) is a subject of debate and is limited to observational data. We report the first meta-analysis that exclusively assessed randomized controlled trials (RCTs) to address this gap.
Methods: A systematic review and meta-analysis was conducted, incorporating all available RCTs that compared MMAE plus standard of care (SOC) versus SOC alone for cSDH usingeither Onyx, n-BCA, and Squid as embolic agent for embolization. Primary outcomes were the rate of hematoma recurrence/progression and the need for reoperation. Secondary outcomes included serious adverse events (SAE), all-cause mortality, functional independence (defined as a Modified Rankin Scale (mRS) score of 0-2), and the rate of successful embolization. To assess heterogeneity, a fixed-effect or random-effects model was applied, depending on statistical significance (I²>50%, P < 0.1).
Results: Four RCTs, with 894 patients in the MMAE plus SOC group and 914 patients in the SOC alone group, were identified and met our standard for analysis. Results revealed significant superiority of n-BCA compared to Onyx and Squid in lower all-cause mortality at last follow-up. There was no significant difference in using Onyx, Squid, and n-BCA in recurrence at the last follow-up (P = 0.36), reoperation at the last follow-up (P = 0.55), and successful embolization (P = 0.52), and 90-day functional independence (P = 0.076) between trials. Additionally, further analysis on safety outcomes showed no significant difference between embolic agents in SAE at last follow-up (P = 0.78), embolization-related complications (P = 0.087), new onset ischemic stroke (P = 0.98), and deep venous thrombosis (P = 0.94).
Conclusion: This meta-analysis of RCTs suggests that while n-BCA is associated with lower all-cause mortality compared to Onyx and Squid in MMAE for cSDH, all three embolic agents demonstrate comparable efficacy and safety.
Keywords: Chronic subdural hematoma; Embolic agents; Middle meningeal artery embolization; Onyx; Squid; n-BCA.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics and consent to participate declarations: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Adjunct middle meningeal artery embolization versus surgery alone for chronic subdural hematoma: A meta-analysis and trial sequential analysis of randomized controlled trials.J Clin Neurosci. 2025 Jul;137:111307. doi: 10.1016/j.jocn.2025.111307. Epub 2025 May 12. J Clin Neurosci. 2025. PMID: 40359787 Review.
-
Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis of three randomized controlled trials and review of ongoing trials.Acta Neurochir (Wien). 2025 Jun 10;167(1):166. doi: 10.1007/s00701-025-06587-4. Acta Neurochir (Wien). 2025. PMID: 40493076 Free PMC article.
-
Particle embolic agents for embolization of middle meningeal artery in the treatment of chronic subdural hematoma: A systematic review and meta-analysis.Interv Neuroradiol. 2024 Feb;30(1):94-104. doi: 10.1177/15910199221125977. Epub 2022 Sep 13. Interv Neuroradiol. 2024. PMID: 36112765 Free PMC article.
-
Middle Meningeal Artery Embolization for Chronic Subdural Hematoma Using N-Butyl Cyanoacrylate With a D5W Push Technique: A Multicentric North American Study of 269 Patients.Oper Neurosurg. 2025 Jun 1;28(6):817-823. doi: 10.1227/ons.0000000000001369. Epub 2024 Sep 23. Oper Neurosurg. 2025. PMID: 39311581
-
Natural History of Chronic Subdural Hematoma Following Middle Meningeal Artery Embolization: A Retrospective Analysis.World Neurosurg. 2025 Feb;194:123501. doi: 10.1016/j.wneu.2024.11.084. Epub 2024 Dec 26. World Neurosurg. 2025. PMID: 39617341
References
-
- Chen H, Colasurdo M, Kan PT (2023) Middle meningeal artery embolization as standalone treatment versus combined with surgical evacuation for chronic subdural hematomas: systematic review and meta-analysis. Published Online September 29. https://doi.org/10.3171/2023.7.JNS231262
-
- Moshayedi P, Liebeskind DS (2020) Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design. Front Neurol 11. https://doi.org/10.3389/fneur.2020.00923
-
- Kan P (2024) Middle meningeal artery embolization and nonacute subdural hematoma. N Engl J Med. Published Online November 20. https://doi.org/10.1056/NEJMe2410915
-
- Abouzari M, Rashidi A, Rezaii J et al (2007) The role of postoperative patient posture in the recurrence of traumatic chronic subdural hematoma after burr-hole surgery. Neurosurgery 61(4):794–797 discussion 797. https://doi.org/10.1227/01.NEU.0000298908.94129.67 - DOI - PubMed
-
- Oh HJ, Lee KS, Shim JJ, Yoon SM, Yun IG, Bae HG (2010) Postoperative course and recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 48(6):518–523. https://doi.org/10.3340/jkns.2010.48.6.518 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous